Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP-Guideline study. Adopted according to OECD SIDS (public available peer reviewed source). The original source is available and has been reviewed.

Data source

Referenceopen allclose all

Reference Type:
publication
Title:
Unnamed
Year:
1996
Reference Type:
secondary source
Title:
SIDS Initial Assessment Report for 11th SIAM
Author:
OECD SIDS
Year:
2003
Bibliographic source:
UNEP Publications

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
3,4-dichlorobut-1-ene
EC Number:
212-079-0
EC Name:
3,4-dichlorobut-1-ene
Cas Number:
760-23-6
Molecular formula:
C4H6Cl2
IUPAC Name:
3,4-dichlorobut-1-ene
Details on test material:
- Name of test material (as cited in study report): 3,4-dichlorobut-1-ene
- Analytical purity: 99%

Method

Target gene:
his operon, trp operon
Species / strain
Species / strain / cell type:
other: S.typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA
Metabolic activation:
with and without
Metabolic activation system:
Rat liver, induced with phenobarbital and 5,6-benzoflavone
Test concentrations with justification for top dose:
-S9 mix: 0, 250 -2500 µg/plate (TA100 and TA1535); 0, 39 - 2500 µg/plate (WP2); 0, 78 - 2500 µg/plate (TA98); 39 - 2500 µg/plate (TA1537)
+S9 mix: 0, 1000 - 3000 (TA100); 0, 500 - 2500 µg/plate (TA1535); 0, 39 - 2500 µg/late (TA1537 and WP2); 0, 39 - 5000 µg/plate (TA98).
Vehicle / solvent:
acetone
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
acetone
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-Aminoanthracene (five strains,+S9 mix)
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
acetone
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
Remarks:
Migrated to IUCLID6: TA1535; -S9 mix
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
acetone
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide (TA100, WP2, TA98; -S9 mix)
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
acetone
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
Remarks:
Migrated to IUCLID6: TA1537; -S9 mix
Details on test system and experimental conditions:
METHOD OF APPLICATION: Plate incubation method
NUMBER OF REPLICATIONS: 2




DETERMINATION OF CYTOTOXICITY
- Method: mitotic index

Results and discussion

Test results
Species / strain:
other: S.typhimurium TA100, TA1535, TA98, TA1537, Escherichia coli WP2 uvrA
Metabolic activation:
with and without
Genotoxicity:
positive
Remarks:
Salm. typh. TA 1535
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
This chemical induced gene mutations in the S. typhimurium TA 1535. Toxicity was observed at 625 µg/plate (TA98 and TA1537), 850 µg/plate (TA100), 1000 µg/plate (TA1535) and 1250 µg/plate (WP2) with the -S9 mix, and at 1250 µg/plate (WP2, TA98 and TA1537), 1500 µg/plate (TA1535) and 2200 µg/plate (TA100) with the +S9 mix.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Table1. Results of confirmation test (I) in reverse mutation test of 3,4 -dichloro-1 -butene on bacteria

 With (-) or Without (+) S9 mix  Test substance dose (µg/plate)     Number of revertants (number of colonies/plate, mean±SD)
 S9 mix -       Base-pair substitution type
 -    TA100  TA1535
 -  0   148±7.0  16±3.6
 -  250    186±26.2  20±4.9
 -  400    222±37.3  33±3.1
 -  550    264±29.9  30±4.0
 - 700    282±11.9  35±5.5
 -  850    271±6.7  48±3.5
 -  1000    288±62.1*  45±8.1*
 Positive control S9 mix (-)  Chemical  AF2  SA
   Dose (µg/plate)  0.01 0.5 
   Number of colonies / plate  729±33.4  178±7.0

AF2: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide, SA: Sodium azide

*: Inhibition was observed against growth of the bacteria.

Table 2. Results of confirmation test (I) in reverse mutation test of 3,4 -dichloro-1 -butene on bacteria

  With (-) or Without (+) S9 mix   Test substance dose (µg/plate)      Number of revertants (number of colonies/plate, mean±SD)   
      Base-pair substitution type  Frameshift type   
 S9 mix -    WP2uvrA  TA98  TA1537
 -  0  22±4.6  23±4.0  
 -  39    24±4.0  ND  
 -  78   27±7.1  25±1.5  
 -  156   27±5.1   29±6.1  
 -  313  31 ± 1.5  22±2.3  
 -  625  28±6.1  25±2.1  
 - 1250   28±5.5*  24±4.5*  
 -  2500    0±0.0*  
         
 S9 mix +  0  18±4.6  31±5.0  10±1.2
 +  39  24±0.6  30±3.1  9±2.3
 +  78  25±2.1  27± 10.4  12±3.6
 +  156  23±10.1 27±3.5   11±4.0
 +  313  26±5.3  24±10.4  9±2.3
 +  625  17±6.8  30±10.4  9±2.0
 +  1250  25±3.6*  19±5.5*  6±1.2*
 Positive control S9 mix -  Chemical  AF2  AF2  
   Dose (µg/plate)  0.01  0.1  
   Number of colonies / plate  161±10.8  893±24.0  
  Positive control S9 mix +  Chemical  2AA  2AA  2AA
   Dose (µg/plate)  10  0.5  2
    Number of colonies / plate  1357±21.4  381±33.5  261±22.0

AF2: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide, 2AA: 2 -Aminoantthracene

*: Inhibition was observed against growth of the bacteria.

Table 3. Results of confirmation test (I) in reverse mutation test of 3,4 -dichloro-1 -butene on bacteria

  With (-) or Without (+) S9 mix  Test substance dose (µg/plate)    Number of revertants (number of colonies/plate, mean±SD) 
 S9 mix (-)  0  113±15.0
 -  250  190±14.4
 -  400  206±31.0
 -  550  196±19.3
 -  700  214±8.3
 -  850  203±8.3
 -  1000  219±11.6
 Positive control S9 mix (-)  Chemical  AF2
   Dose (µg/plate)  0.01
   Number of colonies/plate  654±28.2
     
     

AF2: 2-(2-Furyl)-3-(5-nitro-2-furyl)acrylamide, 2AA: 2 -Aminoantthracene

*: Inhibition was observed against growth of the bacteria.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
positive TA1535 at 1000µg/plate
Executive summary:

MHW, Japan (1996)

3,4-DCB has been tested for bacterial reverse mutation in Salmonella typhimurium and Escherichia coli with and without an exogenous metabolic activation by OECD TG 471 test; at the following dosage: -S9 mix, 0, 250 -2500 µg/plate (TA100 and TA1535), 0, 39 - 2500 µg/plate (WP2), 0, 78 - 2500 µg/plate (TA98) and 39 - 2500 µg/plate (TA1537). This chemical shows mutagenicity only in TA1535 at 1000 µg/plate, but not in other Salmonella typhimurium strains or Escherichia coli strain. In the case of TA1535, the number of induced colonies/plate, indicates that this chemical is weakly mutagenic.